The palliative effects of folic acid on retinal microvessels in diabetic retinopathy via regulating the metabolism of DNA methylation and hydroxymethylation
- PMID: 34874218
- PMCID: PMC8809984
- DOI: 10.1080/21655979.2021.2003924
The palliative effects of folic acid on retinal microvessels in diabetic retinopathy via regulating the metabolism of DNA methylation and hydroxymethylation
Abstract
Diabetic retinopathy (DR) is one of the severe microvascular complications of diabetes. The protective effects of FA on retinal vascular endothelial cells against high glucose levels involve in multiple aspects in DR; however, the underlying mechanism is not fully elucidated. In present study, we investigated the transcriptome as well as genome-wide DNA methylation and hydroxymethylation signature in human retinal microvascular endothelial ACBRI 181 cells cultured within high glucose (HG) medium supplemented with or without FA by RNA-seq, MeDIP-seq, and hMeDIP-seq. Total 3308 differential expressed genes (DEGs) were involved in multiple biological processes and molecular functions containing angiogenesis, inflammation, S-adenosyl methionine metabolism, and hypoxia response. Moreover, the global DNA methylation and hydroxymethylation in ACBRI 181 cells with FA treatment were both compromised compared to HG. Combined with transcriptome data, four subclusters of DEGs with hyper- or hypomethylated promoters were further verified. Unexpectedly, promoters of these 487 genes all displayed a pattern of increased DNA hydroxymethylation. Furthermore, hyperglycemia rat model was established and administered with FA. The DNA methylation and hydroxymethylation changes of selected target genes COL1A1, ITGA7, MMP-14, and VEGFB confirmed by MeDIP-qPCR were consistent with the results in human ACBRI 181 cells. Finally, the presence of activated DNMT1 and TET2 induced by FA was determined in ACBRI 181 cells and hyperglycemia rat. Taken together, this research provided a resource of expression and epigenetic profiles in retinal microvascular endothelial cell, emphasizing a pharmacological mechanism of FA on DNA methylation and hydroxymethylation regulation in retinal microvessel cells of DR.
Keywords: DNA hydroxymethylation; DNA methylation; Diabetic retinopathy; folic acid.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures



Similar articles
-
DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway.Am J Physiol Endocrinol Metab. 2021 Mar 1;320(3):E598-E608. doi: 10.1152/ajpendo.00089.2020. Epub 2020 Dec 7. Am J Physiol Endocrinol Metab. 2021. PMID: 33284093
-
Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation.Int J Mol Sci. 2020 Mar 5;21(5):1771. doi: 10.3390/ijms21051771. Int J Mol Sci. 2020. PMID: 32150828 Free PMC article.
-
Epigenetics and Mitochondrial Stability in the Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy.Sci Rep. 2020 Apr 20;10(1):6655. doi: 10.1038/s41598-020-63527-1. Sci Rep. 2020. PMID: 32313015 Free PMC article.
-
Microvascular complications and diabetic retinopathy: recent advances and future implications.Future Med Chem. 2013 Mar;5(3):301-14. doi: 10.4155/fmc.12.206. Future Med Chem. 2013. PMID: 23464520 Free PMC article. Review.
-
Unraveling the role of genetics in the pathogenesis of diabetic retinopathy.Eye (Lond). 2019 Apr;33(4):534-541. doi: 10.1038/s41433-019-0337-y. Epub 2019 Jan 24. Eye (Lond). 2019. PMID: 30679875 Free PMC article. Review.
Cited by
-
Traversing the epigenetic landscape: DNA methylation from retina to brain in development and disease.Front Cell Neurosci. 2024 Nov 29;18:1499719. doi: 10.3389/fncel.2024.1499719. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39678047 Free PMC article. Review.
-
Therapeutic effect of folic acid combined with decitabine on diabetic mice.Int J Ophthalmol. 2023 Nov 18;16(11):1766-1772. doi: 10.18240/ijo.2023.11.05. eCollection 2023. Int J Ophthalmol. 2023. PMID: 38028519 Free PMC article.
-
New perspectives on DNA methylation modifications in ocular diseases.Int J Ophthalmol. 2025 Feb 18;18(2):340-350. doi: 10.18240/ijo.2025.02.19. eCollection 2025. Int J Ophthalmol. 2025. PMID: 39967986 Free PMC article. Review.
-
TET2-mediated ECM1 hypomethylation promotes the neovascularization in active proliferative diabetic retinopathy.Clin Epigenetics. 2024 Jan 3;16(1):6. doi: 10.1186/s13148-023-01619-1. Clin Epigenetics. 2024. PMID: 38172938 Free PMC article.
-
DNA methylation profiling reveals novel pathway implicated in cardiovascular diseases of diabetes.Front Endocrinol (Lausanne). 2023 Feb 15;14:1108126. doi: 10.3389/fendo.2023.1108126. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36875456 Free PMC article.
References
-
- Meleth AD, Agron E, Chan CC, et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2005;46(11):4295–4301. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous